Lucid Diagnostics's three largest insider shareholders as of May 14, 2026 are Lishan Aklog (Chief Executive Officer, 3.64Mn shares), Lishan Aklog (Chief Executive Officer, 1.17Mn shares), Michael Adam Gordon (General Counsel And Secretary, 1.00Mn shares).
| Holder | Position | Shares (Direct) | Shares (Indirect) | Report Date |
|---|---|---|---|---|
| Lishan Aklog | Chief Executive Officer | 3,636,627 | 0 | 24 Feb, 2026 |
| Lishan Aklog | Chief Executive Officer | 1,166,627 | 0 | 07 May, 2024 |
| Michael Adam Gordon | General Counsel And Secretary | 1,000,000 | 0 | 24 Feb, 2026 |
| Dennis Matheis | - | 788,443 | 0 | 24 Feb, 2026 |
| James L Cox | - | 405,120 | 0 | 24 Feb, 2026 |
| John R Palumbo | - | 338,000 | 0 | 24 Feb, 2026 |
| Stanley Lapidus | - | 337,392 | 0 | 24 Feb, 2026 |
| Ronald M Sparks | - | 320,460 | 0 | 24 Feb, 2026 |
| Jacque J Sokolov | - | 320,460 | 0 | 24 Feb, 2026 |
| Debra White | - | 235,800 | 0 | 24 Feb, 2026 |
| Stanley Lapidus | - | 101,592 | 0 | 27 Sep, 2023 |
* Please note that the shares above only reflect shares from the fund portfolio and the institutional portfolio. Shares from the personal portfolio are excluded from this Institutional Ownership Page. See these insiders' latest transactions here on Insider Page.
| Transaction Date | Insider Name | Security Class | Transaction Type | Shares Traded | Price | Shares Remaining | Ownership | Code |
|---|---|---|---|---|---|---|---|---|
| 20 Feb, 2026 | Jacque J Sokolov | Common Stock | A | 123,000 | $0.00 | 320,460 | D | A |
| 20 Feb, 2026 | Michael Adam Gordon | Common stock | A | 300,000 | $0.00 | 1,000,000 | D | A |
| 20 Feb, 2026 | Debra White | Common Stock | A | 123,000 | $0.00 | 235,800 | D | A |
| 20 Feb, 2026 | Stanley Lapidus | Common Stock | A | 123,000 | $0.00 | 337,392 | D | A |
| 20 Feb, 2026 | Dennis Matheis | Common Stock | A | 123,000 | $0.00 | 788,443 | D | A |
| 20 Feb, 2026 | John R Palumbo | Common Stock | A | 123,000 | $0.00 | 338,000 | D | A |
| 20 Feb, 2026 | Ronald M Sparks | Common stock | A | 123,000 | $0.00 | 320,460 | D | A |
| 20 Feb, 2026 | James L Cox | Common Stock | A | 123,000 | $0.00 | 405,120 | D | A |
| 20 Feb, 2026 | Lishan Aklog | Common Stock | A | 2,170,000 | $0.00 | 3,636,627 | D | A |
| 06 Oct, 2025 | John R Palumbo | Employee stock option (right to buy) | A | 215,000 | $0.00 | 215,000 | D | A |
| 20 Aug, 2025 | Dennis Matheis | Common Stock | A | 100,000 | $1.02 | 665,443 | D | P |
| 20 May, 2025 | Dennis Matheis | Common Stock | A | 187,098 | $1.30 | 402,541 | D | P |
| 20 May, 2025 | Dennis Matheis | Common Stock | A | 187,098 | $1.30 | 187,098 | D | P |
| 21 May, 2025 | Dennis Matheis | Common Stock | A | 129,684 | $1.32 | 316,782 | D | P |
| 21 May, 2025 | Dennis Matheis | Common Stock | A | 129,684 | $1.32 | 532,225 | D | P |
| 22 May, 2025 | Dennis Matheis | Common Stock | A | 33,218 | $1.32 | 350,000 | D | P |
| 22 May, 2025 | Dennis Matheis | Common Stock | A | 33,218 | $1.32 | 565,443 | D | P |
| 20 Feb, 2025 | Debra White | Common Stock | A | 112,800 | $0.00 | 112,800 | D | A |
| 20 Feb, 2025 | Stanley Lapidus | Common Stock | A | 112,800 | $0.00 | 214,392 | D | A |
| 20 Feb, 2025 | Jacque J Sokolov | Common Stock | A | 112,800 | $0.00 | 197,460 | D | A |